| 英文名称 | 中文名称 | CAS | MF |
|
N-[(1R)-2,3-Dihydro-6-hydroxy-1H-inden-1-yl]carbamic acid tert-butyl ester
|
N-[(1R)-2,3-二氢-6-羟基-1H-茚-1-基]氨基甲酸叔丁酯
|
947674-87-5
|
C14H19NO3
|
|
NR1, CT, 23aa (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
NR1, CT, 21aa (NMDA Receptor, N-methyl-D-aspartate Receptor)
|
|
|
|
|
N-[(1R)-1-[4-[(2,4-DIMETHOXYPHENYL)METHYL]-5-(2-PHENYYLETHYL)-4H-1,2,4-TRIAZOL-3-YL]-2-(1H-INDOL-3-YL)ETHYL]-2-PYRIDINECARBOXAMIDE
|
N-[(1R)-1-[4-[(2,4-DIMETHOXYPHENYL)METHYL]-5-(2-PHENYYLETHYL)-4H-1,2,4-TRIAZOL-3-YL]-2-(1H-INDOL-3-YL)ETHYL]-2-PYRIDINECARBOXAMIDE
|
925239-03-8
|
C35H34N6O3
|
|
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
|
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
|
155488-25-8
|
C28H30N6O3
|
|
N-[(1R)-3-(Dimethylamino)-1-(hydroxymethyl)-3-oxopropyl]carbamic Acid Phenylmethyl Ester
|
[(R)-4-(二甲基氨基)-1-羟基-4-氧代丁烷-2-基]氨基甲酸苄酯
|
870812-29-6
|
C14H20N2O4
|
|
N-[(1R)-5-(1,1-Dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea
|
N-(5-叔丁基茚满-1-基)-N'-(1H-吲唑-4-基)脲
|
808756-71-0
|
C21H24N4O
|
|
N-{[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}-5-nitropyrimidin-4-amine
|
|
|
C10H14N4O4
|
|
N4-{[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}pyrimidine-4,5-diamine
|
|
|
C10H16N4O2
|
|
(-)-N-[(R)-4,8-Dimethyl-7-nonenyl]phthalimide
|
|
|
C19H25NO2
|
|
N-[(5R,6α,7α,10β)-2,10-Dimethyl-7-isopropylspiro[4.5]dec-1-en-6-yl]formamide
|
|
|
|
|
N-[(2R)-2,4-Dimethyl-2-[(cyclopentylcarbonyl)amino]pentanoyl]glycinamide
|
|
|
C15H27N3O3
|
|
(-)-N-[(R)-2,3-Dimethylbutyryl]-4-morpholinecarbothioamide
|
|
|
C11H20N2O2S
|
|
(+)-N-[(R)-1-(5,8-Dimethyl-2-naphtyl)ethyl]benzamide
|
|
|
C21H21NO
|
|
N-[(1R)-1,3-Dimethyl-4-hydroxybutyl]adenosine
|
|
|
C16H25N5O5
|
|
(-)-N-[(R)-3,4-Dimethoxy-α-methylphenethyl]-p-toluenesulfonamide
|
|
|
|
|
N-[(2R)-2,4-Dimethyl-2-[[[(2S)-pyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide
|
|
|
C14H26N4O3
|
|
N-[(1R)-1,3-Dimethylbutyl]adenosine
|
|
|
C16H25N5O4
|
|
(-)-N-[(R)-3,7-Dimethyl-6-octenyl]acetamide
|
|
|
C12H23NO
|
|
N-[(2R)-2,4-Dimethyl-2-[[[1H-pyrrol-2-yl]carbonyl]amino]pentanoyl]glycinamide
|
|
|
C14H22N4O3
|
|
N-[[R,(-)]-2-(3,3-Dimethylpiperidino)-1-methylethyl]-N-(2-pyridyl)propionamide
|
|
24608-96-6
|
|
|
(+)-N-[(R)-1-(3,4-Dimethoxybenzoyl)ethyl]phthalimide
|
|
|
C19H17NO5
|
|
(+)-N-[(R)-1,2-Dimethylpropyl]-p-toluenesulfonamide
|
|
|
C12H19NO2S
|
|
(+)-N-[(R)-4,α-Dimethylbenzyl]benzamide
|
|
|
|
|
(-)-N-[(R)-1,2-Dimethylpropyl]-4-nitrobenzamide
|
|
|
C12H16N2O3
|
|
N-[(R)-3,3-Dimethyl-1-oxo-2,4-bis(trimethylsiloxy)butyl]-β-alanine methyl ester
|
|
55591-03-2
|
C16H35NO5Si2
|
|
N-[(2R)-2,4-Dimethyl-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide
|
|
|
C14H24N4O4
|
|
N-[(1R)-1,3-Dimethylbutyl]-9H-purin-6-amine
|
|
|
C11H17N5
|
|
(+)-N-[(R)-β-[2-(2,4-Dinitrophenyl)hydrazono]-α-methylphenethyl]-2,2,2-trifluoroacetamide
|
|
|
|
|
(+)-N-[(R)-1,2-Diphenylethyl]-2-methylenesuccinimide
|
|
|
C19H17NO2
|
|
(-)-N-[(R)-1,2-Diphenyl-2-oxoethyl]phthalamidic acid
|
|
|
C23H18N2O5
|
|
(+)-N-[(R)-1,2-Diphenylethyl]acetamide
|
|
|
C16H17NO
|
|
(+)-N-[(R)-1,2-Diphenylethyl]-N-nitrosoacetamide
|
|
|
C16H16N2O2
|
|
(+)-N-[(R)-1,2-Diphenylethyl]nicotinamide
|
|
|
C20H18N2O
|
|
(+)-N-[(R)-1,2-Diphenylethyl]maleimide
|
|
|
C18H15NO2
|
|
(+)-N-[(R)-1,2-Diphenylethyl]phthalimide
|
|
|
C22H17NO2
|
|
nrdI protein
|
|
|
|
|
(-)-N-[(R)-2-(1,3-Dithiolane-2-yl)-1-methylethyl]phthalimide
|
|
|
C14H15NO2S2
|
|
(+)-N-[(R)-α-(1,3-Dithiolane-2-yl)-p-methoxyphenethyl]phthalimide
|
|
|
|
|
(-)-N-[(R)-1-(1,3-Dithiolane-2-yl)propyl]phthalimide
|
|
|
C14H15NO2S2
|
|
(-)-N-[(R)-1-(1,3-Dithiolane-2-yl)ethyl]phthalimide
|
|
|
C13H13NO2S2
|
|
(+)-N-[(R)-α-[2-(1,3-Dithiolane-2-yl)-1,3-dithiolane-2-yl]-p-methoxyphenethyl]phthalimide
|
|
|
|
|
NR1, CT (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
NREB protein
|
|
|
|
|
NreB protein (GATA factor)
|
|
|
|
|
N4Py cpd
|
|
|
|
|
N-[(1R,2E)-1,3-Dimethyl-4-acetoxy-2-butenyl]adenosine 2'-O,3'-O,5'-O-trisacetate
|
|
|
|
|
N-[(1R,2E)-1,3-Dimethyl-4-acetoxy-2-butenyl]adenosine
|
|
|
C18H25N5O6
|
|
N-[(1R,2E)-1,3-Dimethyl-4-hydroxy-2-butenyl]adenosine
|
|
|
C16H23N5O5
|
|
N-[(1R)-1-(4-Cyanophenyl)ethyl]carbamic acid tert-butyl este
|
[(1R)-1-(4-氰基苯基)乙基]氨基甲酸叔丁酯
|
1149727-73-0
|
C14H18N2O2
|
|
(+)-N-[(R)-α-Cyanobenzyl]-p-toluenesulfonamide
|
|
|
|
|
(+)-N-[(R)-α-Cyano-4-acetyloxy-3-methoxy-α-methylphenethyl]acetamide
|
|
|
|
|
(-)-N-[(R)-3-Cyano-1-methyl-3,3-diphenylpropyl]-N-methylformamide
|
|
|
C19H20N2O
|
|
(+)-N-[(R)-6-Cyano-3-methylhexyl]acetamide
|
|
|
C10H18N2O
|
|
(+)-N-[(R)-1-Cyanoethyl]acetamide
|
|
|
C5H8N2O
|
|
(-)-N-[(R)-α-Cyanobenzyl]acetamide
|
|
|
|
|
(+)-N-[(R)-1-Cyanoethyl]benzamide
|
|
|
C10H10N2O
|
|
(+)-N-[(R)-1-Cyano-2-methylpropyl]benzamide
|
|
|
C12H14N2O
|
|
(-)-N-[(R)-2-Cyclohexyl-1-methylethyl]-2-methylenesuccinimide
|
|
|
C14H21NO2
|
|
(-)-N-[(R)-2-Cyclohexyl-1-methylethyl]phthalimide
|
|
|
C17H21NO2
|
|
(-)-N-[(R)-1-Cyclohexyl-2-benzoyloxyethyl]dibenzoylamine
|
|
|
C29H29NO4
|
|
(+)-N-[(R)-1-Cyclohexyl-2-hydroxyethyl]benzamide
|
|
|
C15H21NO2
|
|
(+)-N-[(R)-1-Cyclohexyl-2-(acetyloxy)ethyl]benzamide
|
|
|
C17H23NO3
|
|
(-)-N-[(R)-1-Cyclohexylethyl]phthalimide
|
|
|
C16H19NO2
|
|
(+)-N-[(R)-1-Cyclohexylethyl]-2-methylenesuccinimide
|
|
|
C13H19NO2
|
|
(+)-N-[(R)-1-Cyclohexyl-2-hydroxyethyl]acetamide
|
|
|
C10H19NO2
|
|
(-)-N-[(R)-2-Cyclohexyl-1-methylethyl]benzamide
|
|
|
C16H23NO
|
|
(-)-N-[(R)-2-Cyclohexyl-1-methylethyl]maleimide
|
|
|
C13H19NO2
|
|
(+)-N-[(R)-1-Cyclohexyl-2-acetyloxyethyl]acetamide
|
|
|
C12H21NO3
|
|
N-[(R)-2-[[[(Dodecanoyl)amino]acetyl]amino]-5-methylhexanoyl]-L-valine methyl ester
|
|
|
C27H51N3O5
|
|
N-[[(2R)-1-Dodecylpyrrolidin-2β-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
N-[(1R,2E,4E,6S,8E,10E,12S,14E,17S)-6,12-Dihydroxy-3,9,15,17-tetramethyl-16-oxocycloheptadeca-2,4,8,10,14-pentene-1-yl]-2-hydroxypropanamide
|
|
51741-82-3
|
C24H35NO5
|
|
Nrd1 protein
|
|
|
|
|
NRF-160
|
|
|
|
|
NQO2 HUMAN
|
|
|
|
|
N-[2-[[(12R,9E)-12-Hydroxy-1-oxo-9-octadecenyl]amino]ethyl]-N,N,N',N',N'-pentamethyl-1,3-propanediaminium
|
|
|
C28H59N3O2+2
|
|
NrfA protein
|
|
|
|
|
NQO1 (NAD(P)H Dehydrogenase Quinone 1)
|
|
|
|
|
NPY ( Neuropeptide Y)
|
神经肽 Y(抗原)
|
|
|
|
NPY1 nudix hydrolase
|
|
|
|
|
N-[[(2R)-2α,6α-Epoxy-6-methyl-1,4,5,6-tetrahydro-2H-3-benzoxocin]-4β-yl]-N-(2-dimethylaminoethyl)acetamide
|
|
|
|
|
N-[[(2R)-2α,6α-Epoxy-6-methyl-1,4,5,6-tetrahydro-2H-3-benzoxocin]-4β-yl]-N-methylacetamide
|
|
|
|
|
N-[[(2R)-2α,6α-Epoxy-6-methyl-1,4,5,6-tetrahydro-2H-3-benzoxocin]-4β-yl]-N-methoxyethylacetamide
|
|
|
|
|
Nre protein
|
|
|
|
|
NR2E3 protein
|
|
|
|
|
Np-ypt3 protein
|
|
147995-33-3
|
|
|
N-Pyrazinylcarbonyl-L-phenylalanine-d8
|
|
|
C14H13N3O3
|
|
N-(pyrazine-2-yl-carbonyl)-L-phenylalanine
|
硼替佐米中间体
|
1093959-75-1
|
C14H12N3O3.Na
|
|
N-(1-(pyrazin-2-yl)ethyl)cyclopropanaMine hydrochloride, 98+% C9H14ClN3, MW: 199.68
|
N-环丙基-ALPHA-甲基-2-吡嗪甲胺盐酸盐
|
1185320-04-0
|
C9H14ClN3
|
|
N-(3-{[(2-pyrazinylcarbonyl)amino]methyl}benzyl)-2-pyrazinecarboxamide
|
|
548779-52-8
|
C18H16N6O2
|
|
N-{2-[(2-pyrazinylcarbonyl)amino]ethyl}-2-pyrazinecarboxamide
|
|
|
C12H12N6O2
|
|
N-(pyrazin-2-yl)-1-azabicyclo[2.2.2]octan-3-amine
|
|
|
C11H16N4
|
|
N-[3-(2-pyrazinyloxy)phenyl]-N'-[3-(trifluoromethyl)phenyl]urea
|
|
|
C18H13F3N4O2
|
|
N-[3-(2-pyrazinyloxy)phenyl]-4-(trifluoromethoxy)benzenesulfonamide
|
|
|
C17H12F3N3O4S
|
|
N1-pyrazin-2-yl-4-chlorobenzamide
|
|
|
|
|
N-[2-(2-pyrazinylsulfanyl)phenyl]benzenesulfonamide
|
|
|
C16H13N3O2S2
|
|
N-[3-(2-pyrazinyloxy)phenyl]-3-(trifluoromethyl)benzenecarboxamide
|
|
|
C18H12F3N3O2
|
|
N-[5-(2-pyrazinylsulfanyl)-1,3,4-thiadiazol-2-yl]acetamide
|
|
|
C8H7N5OS2
|
|
N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester
|
硼替佐米杂质G
|
73058-37-4
|
C15H15N3O3
|
|
N-PYRAZINYLCARBONYLPHENYLALANINE
|
N-PYRAZINYLCARBONYLPHENYLALANINE
|
|
C14H13N3O3
|